New therapies in atopic dermatitis
Keyword(s):
Atopic dermatitis (AD) is one of the most common inflammatory skin diseases. Despite of this, the pathomechanism of the disease is still not fully understood. In recent years, several scientific results led to the better understanding of the disease. Meantime, new therapeutical options have emerged which were developed specifically for AD patients. In this manuscript new therapies, namely dupilumab and baricitinib, which are already licenced in Hungary, are reviewed. A detailed description of therapies e.g. biological therapy, small molecular weight drugs, topical therapy and antipruritics which are currently in clinical research have been also summarized.
2020 ◽
Vol 34
(10)
◽
pp. 2168-2169
2004 ◽
Vol 51
(3)
◽
pp. 101-110
◽
Keyword(s):
2006 ◽
Vol 1
(3)
◽
pp. 343-354
◽